Mutual of America Capital Management LLC Has $2.05 Million Stake in Orthofix Medical Inc. (NASDAQ:OFIX)

Mutual of America Capital Management LLC trimmed its holdings in Orthofix Medical Inc. (NASDAQ:OFIX) by 5.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,347 shares of the medical device company’s stock after selling 9,029 shares during the period. Mutual of America Capital Management LLC’s holdings in Orthofix Medical were worth $2,054,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quantbot Technologies LP acquired a new stake in shares of Orthofix Medical in the first quarter valued at approximately $39,000. PNC Financial Services Group Inc. raised its position in Orthofix Medical by 23.8% during the second quarter. PNC Financial Services Group Inc. now owns 2,960 shares of the medical device company’s stock valued at $53,000 after purchasing an additional 570 shares in the last quarter. UBS Group AG raised its position in Orthofix Medical by 2,120.8% during the third quarter. UBS Group AG now owns 2,776 shares of the medical device company’s stock valued at $53,000 after purchasing an additional 2,651 shares in the last quarter. Systematic Financial Management LP acquired a new position in Orthofix Medical during the first quarter valued at approximately $99,000. Finally, State of Wyoming raised its position in Orthofix Medical by 292.4% during the fourth quarter. State of Wyoming now owns 4,882 shares of the medical device company’s stock valued at $100,000 after purchasing an additional 3,638 shares in the last quarter. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

OFIX has been the subject of several research analyst reports. Roth Mkm boosted their price objective on shares of Orthofix Medical from $12.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday, March 7th. StockNews.com downgraded shares of Orthofix Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, March 6th.

Orthofix Medical Stock Up 0.6 %

Shares of NASDAQ:OFIX opened at $13.10 on Friday. The company has a fifty day moving average of $13.75 and a 200-day moving average of $12.90. The company has a market capitalization of $490.07 million, a PE ratio of -3.16 and a beta of 1.04. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.20 and a current ratio of 2.54. Orthofix Medical Inc. has a 52-week low of $9.57 and a 52-week high of $21.60.

Orthofix Medical (NASDAQ:OFIX) last announced its quarterly earnings results on Tuesday, March 5th. The medical device company reported ($0.59) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.60) by $0.01. The company had revenue of $200.42 million during the quarter. Orthofix Medical had a negative net margin of 20.28% and a negative return on equity of 10.63%. On average, equities analysts predict that Orthofix Medical Inc. will post -1.51 EPS for the current fiscal year.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.